Diabetic Nephropathies: all 544 studies
Page 3 of 6. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.
- The Impact of Sitagliptin as an Add on Therapy With Closed Loop Control in Adolescents With Diabetic NephropathyCompletedNCT06115460Phase 3
- Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic ValueActive, not recruitingNCT06097351
- Enhanced Recovery After Surgery for SPK Transplantation RecipientsCompletedNCT06095544Not applicable
- Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)CompletedNCT06006689Phase 2
- Omega-3 Fatty Acids Supplementation Improves Early-stage Diabetic Nephropathy and Subclinical Atherosclerosis in Pediatric Patients With Type 1 DiabetesCompletedNCT05980026Not applicable
- Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot StudyTerminatedNCT05897372Phase 2
- Predictors of Chronic Kidney Disease Among Type 2 Diabetic Patients in Assiut University HospitalsStatus unknownNCT05847400
- To Explore the Anti-oxidative Effects and Inflammation Effects of Soy Protein to Renal Function of End Stage Diabetes Nephropathy PatientsCompletedNCT05840796Not applicable
- Application of Hyperspectral Imaging in the Diagnosis of Glomerular DiseasesStatus unknownNCT05797051
- Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular ComplicationsStatus unknownNCT05787990
- Azilsartan in Patients With Diabetic Kidney Disease and HypertensionStatus unknownNCT05753696Not applicable
- Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With AlbuminuriaCompletedNCT05718375Phase 2
- A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseaseCompletedNCT05709444Phase 2
- Assessment of Urinary Uromodulin and the Corresponding Gene Expression as a Biomarker of Diabetic NephropathyCompletedNCT05695573
- A Study of Participants With Chronic Kidney Disease Previously Treated With REACTTerminatedNCT05694169Phase 1
- A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney DiseaseActive, not recruitingNCT05687890Phase 2
- To Evaluate the Beneficial Effect of Probiotics on DKD Patients and the Role of Gut Microbiota ModulationCompletedNCT05674981Not applicable
- The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKDActive, not recruitingNCT05656963
- Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney DiseaseCompletedNCT05638880Phase 2
- Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 DiabetesCompletedNCT05631119
- Triglyceride-Glucose Index in Diabetic Nephropathy in Type 2diaberes Mellitus PatientsStatus unknownNCT05602532
- Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney DiseaseCompletedNCT05593575Phase 2
- Phase 2 Study of INV-202 in Patients With Diabetic Kidney DiseaseCompletedNCT05514548Phase 2
- Renal Mechanism of SGLT2 InhibitionActive, not recruitingNCT05507892Phase 2
- Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy SubjectsCompletedNCT05492630Phase 1
- Investigational and Comparative Study in the Management of Diabetic NephropathyCompletedNCT05487755Phase 3
- Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic NephropathyStatus unknownNCT05418465Not applicable
- Identification of Diabetic Nephropathy Biomarkers Through TranscriptomicsCompletedNCT05378282
- Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney DiseaseStatus unknownNCT05373004Phase 2/3
- Basic Needs Navigation Intervention to Address Multidimensional Adversity in African Americans With Diabetic Kidney DiseaseCompletedNCT05357742Not applicable
- Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney DiseaseStatus unknownNCT05330390
- Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)Active, not recruitingNCT05319990
- The Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease PatientsStatus unknownNCT05298163Not applicable
- The Hong Kong Diabetes BiobankActive, not recruitingNCT05282680
- Dosimetry of Tc-99m-TilmanoceptCompletedNCT05241522Phase 1
- Basal Plus GLP1-ra on Glycemic Variability in CKDCompletedNCT05218915Phase 4
- Prospective Decision Impact Clinical Utility Trial of KidneyIntelXActive, not recruitingNCT05198284
- The Effects of TMZ on Diabetic NephropathyStatus unknownNCT05147194Phase 2
- Irisin And Diabetic NephropathyStatus unknownNCT05144672
- An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and ProteinuriaCompletedNCT05086549
- Metabolism of Low Carbohydrate and Ketogenic DietCompletedNCT05071287Not applicable
- The Expression of circANKRD36 as a New Biomarker of Diabetic NephropathyStatus unknownNCT05061459
- To Improve the Ability of Early Screening and Diagnosis in Patients With Diabetic NephropathyStatus unknownNCT05047471
- Automatic Segmentation Ultrasound-based Radiomics Technology in Diabetic Kidney DiseaseCompletedNCT05025540
- Non Diabetic Causes of Chronic Kidney Disease in Type 2 Diabetic PatientsCompletedNCT05021705
- Prevention In Community Clinics From Diabetic Kidney DiseaseStatus unknownNCT04988581Not applicable
- Study on the Efficacy and Safety of a Novel Tripterygium Wilfordii Preparation in Reducing Proteinuria in Patients With Diabetic NephropathyCompletedNCT04981613Not applicable
- Relationship Between Serum N/OFQ and Type 2 Diabetic NephropathyStatus unknownNCT04962399
- Prospective Decision Impact Trial of KidneyIntelXActive, not recruitingNCT04960514
- Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.Status unknownNCT04942119Not applicable
- Low Carbohydrate Diet in Diabetic Kidney DiseaseCompletedNCT04931030Not applicable
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 DiabetesActive, not recruitingNCT04929379Phase 2
- A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult Participants With Different Degrees of Reduced Liver Function and in Healthy Participants With Similar Age, Weight and Gender DistributionCompletedNCT04881994Phase 1
- SER150 vs Placebo in Diabetic Kidney DiseaseCompletedNCT04881123Phase 2/3
- First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 DiabetesCompletedNCT04880291Phase 1
- Stem Cell Therapy for Chronic Kidney DiseaseCompletedNCT04869761Phase 1
- SGLT2 Inhibitors Prophylaxis Against Post-contrast Acute Kidney Injury in Diabetic Kidney Disease?Status unknownNCT04853615
- Hyperuricemia and Diabetic NephropathyStatus unknownNCT04799925
- Decision Impact Trial of KidneyIntelXActive, not recruitingNCT04791358
- Possible Role of Roflumilast in Diabetic NephropathyStatus unknownNCT04755946Phase 3
- Pain Neuroscience Education in Diabetic NeuropathyCompletedNCT04721847Not applicable
- Gemigliptin and Biomarkers of Kidney Injury and Vascular CalcificationCompletedNCT04705506Not applicable
- Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney DiseasesCompletedNCT04689074
- A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.WithdrawnNCT04661917Phase 2
- Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 DiabetesCompletedNCT04635670Not applicable
- Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney DiseaseStatus unknownNCT04626323Phase 2
- The Association Between sUCR and the Survival in Patients With DKDStatus unknownNCT04612595
- Kidney Fat in Type 2 Diabetes and the Effects of EzetimibeStatus unknownNCT04589351Phase 3
- Atrasentan in Patients With Proteinuric Glomerular DiseasesActive, not recruitingNCT04573920Phase 2
- MRI Biomarkers in Diabetic Kidney DiseaseCompletedNCT04570735
- Clinical Research of UC-MSCs in the Treatment of Diabetic NephropathyStatus unknownNCT04562025Not applicable
- Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With NephropathyCompletedNCT04549324
- Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and NephropathyCompletedNCT04534439Phase 2
- Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced NephropathyStatus unknownNCT04531163Phase 2/3
- The Predictive Value of Sidestream Dark Field Imaging in Diabetic NephropathyCompletedNCT04403945
- Global Kidney Patient Trials NetworkCompletedNCT04389827
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change DiseaseTerminatedNCT04387448Phase 2
- Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.CompletedNCT04380584
- Niclosamide Role in Diabetic NephropathyCompletedNCT04317430Phase 3
- Renohemodynamic Effects of Combined empagliflOzin and LosARtanCompletedNCT04238702Phase 4
- A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)TerminatedNCT04235621
- Role of Fexofenadine in Diabetic Kidney DiseaseCompletedNCT04224428Phase 3
- Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic NephropathyStatus unknownNCT04216849Phase 1/2
- Determining Serum and Urinary Levels of miRNA 192 and miRNA 25 in Patients With and Without Type 2 Diabetes.CompletedNCT04176276
- Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA CombinationStatus unknownNCT04143412Phase 2
- Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 DiabetesStatus unknownNCT04127084Phase 4
- Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic NephropathyStatus unknownNCT04125329Early Phase 1
- Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in AsiansStatus unknownNCT04119167
- TCF7L2 Gene Polymorphism and AGEs in Diabetic NephropathyStatus unknownNCT04084886
- Control of Renal Oxygen Consumption, Mitochondrial Dysfunction, and Insulin ResistanceCompletedNCT04074668
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and AlbuminuriaStatus unknownNCT04061200Phase 4
- Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.CompletedNCT04027530Phase 4
- Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent DeviceStatus unknownNCT03965975Not applicable
- MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes MellitusActive, not recruitingNCT03945747
- Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)TerminatedNCT03933956Phase 3
- Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.SuspendedNCT03921216
- Glycaemic Markers in Persons With Type 2 Diabetes on HaemodialysisCompletedNCT03909269
- Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.CompletedNCT03889236Not applicable
- Assessment of the Accuracy of Continuous Glucose Sensors in People With Diabetes Undergoing HaemodialysisCompletedNCT03885362Not applicable
- Effects of Fenofibrate Therapy in Diabetic NephropathyStatus unknownNCT03869931Phase 3